120 related articles for article (PubMed ID: 24768849)
1. Preoperative MRI criteria for trials on less radical surgery in Stage IB1 cervical cancer.
Lee JY; Youm J; Kim TH; Cho JY; Kim MA; Suh DH; Lim MC; Kim JW; Park NH; Song YS
Gynecol Oncol; 2014 Jul; 134(1):47-51. PubMed ID: 24768849
[TBL] [Abstract][Full Text] [Related]
2. Postoperative outcomes of MR-invisible stage IB1 cervical cancer.
Park JY; Lee JW; Park BK; Lee YY; Choi CH; Kim TJ; Bae DS; Kim BG; Park JJ; Park SY; Kim CK
Am J Obstet Gynecol; 2014 Aug; 211(2):168.e1-7. PubMed ID: 24607752
[TBL] [Abstract][Full Text] [Related]
3. A model for prediction of parametrial involvement and feasibility of less radical resection of parametrium in patients with FIGO stage IB1 cervical cancer.
Chang SJ; Bristow RE; Ryu HS
Gynecol Oncol; 2012 Jul; 126(1):82-6. PubMed ID: 22516661
[TBL] [Abstract][Full Text] [Related]
4. Magnetic Resonance Imaging as a Valuable Tool for Predicting Parametrial Invasion in Stage IB1 to IIA2 Cervical Cancer.
Kim M; Suh DH; Kim K; Lee HJ; Kim YB; No JH
Int J Gynecol Cancer; 2017 Feb; 27(2):332-338. PubMed ID: 28114236
[TBL] [Abstract][Full Text] [Related]
5. Parametrial involvement in FIGO stage IB1 cervical carcinoma diagnostic impact of tumor diameter in preoperative magnetic resonance imaging.
Kamimori T; Sakamoto K; Fujiwara K; Umayahara K; Sugiyama Y; Utsugi K; Takeshima N; Tanaka H; Gomi N; Takizawa K
Int J Gynecol Cancer; 2011 Feb; 21(2):349-54. PubMed ID: 21721193
[TBL] [Abstract][Full Text] [Related]
6. Identifying a low-risk group for parametrial involvement in microscopic Stage IB1 cervical cancer using criteria from ongoing studies and a new MRI criterion.
Lee JY; Youm J; Kim JW; Cho JY; Kim MA; Kim TH; Suh DH; Lim MC; Park NH; Song YS
BMC Cancer; 2015 Mar; 15():167. PubMed ID: 25885786
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Parametrial Involvement in Early Stages Cervical Cancer With Preoperative Magnetic Resonance Imaging.
He F; Du J; Chen X; He L
Int J Gynecol Cancer; 2018 Nov; 28(9):1758-1765. PubMed ID: 30153214
[TBL] [Abstract][Full Text] [Related]
8. Preoperatively Assessable Clinical and Pathological Risk Factors for Parametrial Involvement in Surgically Treated FIGO Stage IB-IIA Cervical Cancer.
Canaz E; Ozyurek ES; Erdem B; Aldikactioglu Talmac M; Yildiz Ozaydin I; Akbayir O; Numanoglu C; Ulker V
Int J Gynecol Cancer; 2017 Oct; 27(8):1722-1728. PubMed ID: 28617687
[TBL] [Abstract][Full Text] [Related]
9. Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A).
Kato T; Takashima A; Kasamatsu T; Nakamura K; Mizusawa J; Nakanishi T; Takeshima N; Kamiura S; Onda T; Sumi T; Takano M; Nakai H; Saito T; Fujiwara K; Yokoyama M; Itamochi H; Takehara K; Yokota H; Mizunoe T; Takeda S; Sonoda K; Shiozawa T; Kawabata T; Honma S; Fukuda H; Yaegashi N; Yoshikawa H; Konishi I; Kamura T;
Gynecol Oncol; 2015 Apr; 137(1):34-9. PubMed ID: 25662625
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer.
Yamazaki H; Todo Y; Okamoto K; Yamashiro K; Kato H
J Gynecol Oncol; 2015 Oct; 26(4):255-61. PubMed ID: 26197769
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery.
Kodama J; Kusumoto T; Nakamura K; Seki N; Hongo A; Hiramatsu Y
Gynecol Oncol; 2011 Sep; 122(3):491-4. PubMed ID: 21703671
[TBL] [Abstract][Full Text] [Related]
12. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
13. Preoperative magnetic resonance imaging criteria for predicting lymph node metastasis in patients with stage IB1-IIA2 cervical cancer.
He F; Zu S; Chen X; Liu J; Yi Y; Yang H; Wang F; Yuan S
Cancer Med; 2021 Aug; 10(16):5429-5436. PubMed ID: 34278729
[TBL] [Abstract][Full Text] [Related]
14. How important is removal of the parametrium at surgery for carcinoma of the cervix?
Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
Gynecol Oncol; 2002 Jan; 84(1):145-9. PubMed ID: 11748991
[TBL] [Abstract][Full Text] [Related]
15. Radical hysterectomy compared with primary radiation for treatment of stage IB1 cervix cancer.
Doll KM; Donnelly E; Helenowski I; Rosenbloom L; Small W; Schink JC; Lurain JR
Am J Clin Oncol; 2014 Feb; 37(1):30-4. PubMed ID: 22992622
[TBL] [Abstract][Full Text] [Related]
16. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
17. Apparent diffusion coefficient for prediction of parametrial invasion in cervical cancer: a critical evaluation based on stratification to a Likert scale using T2-weighted imaging.
Woo S; Kim SY; Cho JY; Kim SH
Radiol Med; 2018 Mar; 123(3):209-216. PubMed ID: 29058233
[TBL] [Abstract][Full Text] [Related]
18. Lymphadenectomy alone is a feasible option in managing incidentally-detected early-stage cervical cancer after simple hysterectomy without intermediate-risk factors: An application of the concept of less radical surgery.
Jeon HW; Suh DH; Kim K; No JH; Kim YB
Anticancer Res; 2013 Nov; 33(11):5135-41. PubMed ID: 24222161
[TBL] [Abstract][Full Text] [Related]
19. [Identification of low-risk indicators of early stage cervical cancer].
Liu Q; Yang JX; Cao DY; Shen K; Wu M; Pan LY; Xiang Y; Lang JH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):580-4. PubMed ID: 23286402
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic radical hysterectomy after preoperative brachytherapy for stage IB1 cervical cancer: feasibility, results, and surgical implications in a large bicentric study of 162 consecutive cases.
Uzan C; Merlot B; Gouy S; Belghiti J; Haie-Meder C; Nickers P; Fabrice N; Morice P; Leblanc E
Ann Surg Oncol; 2013 Mar; 20(3):872-80. PubMed ID: 22932859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]